-
+2 +2
Biogen Reports Another Tecfidera PML Case
Non-fatal case is the second one for the oral MS drug.
-
+2 +2
Study Evaluates Gilenya's Impact on Central Autonomic Dysfunction In MS With Delayed Heart Rate
In a recent study published in the Journal PLOS One, a team of researchers found that the autonomic cardiovascular dysfunction in MS patients with delayed heart ratere-acceleration upon Fingolimod-initiation suggest that MS-related central autonomic lesions may compromise heart rate re-acceleration.
-
+8 +2
Study on French MS Population Reveals Long Disease Duration is Associated with Higher Mortality
A study recently published in the journal PLoS One revealed an excess mortality rate among French patients with multiple sclerosis (MS) that experience the disease for more than 20 years.
-
+8 +2
Lesion Topography Matters in Multiple Sclerosis
Location in cerebral cortex, more than global white matter lesion volume, tied to disability.
-
+2 +2
Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis
These findings suggest that blood–brain barrier permeability, as measured by magnetic resonance imaging, may provide novel pathological information as a marker of neuroinflammation related to multiple sclerosis, to some extent reflecting cellular permeability of the blood–brain barrier, whereas T2 lesion count may more reflect the length of the subclinical pre-relapse phase.
-
+10 +2
5 Awful Realities Of Life With An 'Invisible Illness'
If you have ever had the plague, no one accused you of faking it to get handicapped parking for your oxen or whatever. Not the case with my particular disease.
-
+2 +2
Identifying MS Gene Mutations Could Make Personalized Treatment Possible
Read about how a mutation is associated with non-response to IFNβ treatment.
-
+1 +1
Biogen Shares Plunge 22% on Poor MS Drug Performance, Slashed Outlook
Revised outlook attributed to lower Tecfidera demand
-
+2 +1
In sickness and in help
My husband is learning to live with his MS, thanks to the American Disabilities Act and because of my own personal history with medical adversity.
-
+14 +1
Multiple sclerosis breakthrough: Scientists develop technology to assist doctors in detection of brain lesions
One of these lesions is not like the others.
-
+2 +1
Biogen's Tecfidera Now The Most Prescribed Oral MS Therapy Globally
Cambridge, Massachusetts based Biogen Inc. has reported its second quarter 2015 results, posting a year-over-year seven percent revenue increase to $2.6 Billion in the quarter.
-
+1 +1
Masitinib Shows Promise in Early Study For Treating Progressive MS Patients
Progressive multiple sclerosis patients treated with AB Science’s lead compound AB07002 (masitinib) in a Phase 3 clinical trial showed positive results in a non futility test
-
+2 +1
Multiple Sclerosis Research: MS Basics - SPASTICITY
I promised to post on spasticity in MS a while back. Hope you find this post useful...
-
+18 +1
The monster under the bed
"What’s the thing you’re most scared MS will do to you?" A heartfelt answer to a a 6-year-old's question.
-
+1 +1
How many multiple sclerosis patients are in the U.S.? No one knows.
Bruce Bebo, executive vice president of research at the National MS Society, says the organization’s estimate of about 400,000 patients in the U.S. is based on epidemiology-based population estimated developed in the 1970s.
-
+1 +1
Altered Immune Cells in Relapsing Remitting Multiple Sclerosis Patients Cause Reduced Immune Capacity
Here authors investigated how polymorphonuclear cells functions, important players of the innate immune system, are altered in multiple sclerosis patients.
-
+1 +1
MSPrecise Shown to be Accurate in Diagnosing RRMS in Study Cohort
The test accurately diagnosed 84% of multiple sclerosis patients from a broad range of subjects with potential neurological diseases.
-
+2 +1
Canadian Pediatric Demyelinating Disease Network Funding To Help Expand Multiple Sclerosis Research
Canadian Pediatric Demyelinating Disease Network gets boost with $3.2 million grant funding to help expand pediatric multiple sclerosis research
-
+12 +1
Scientists ID Cause of Movement, Balance Problems in Multiple Sclerosis
A newly arrived faculty member is part of a research team that found a faulty “brake” within immune cells that may cause many of the symptoms of MS.
-
+2 +1
Multiple Sclerosis FAQs
Discover more about Multiple Sclerosis.
Submit a link
Start a discussion